Hawaiian Eye & Retina 2025

Hawaiian Eye & Retina 2025 is organized by Healio LIVE and will be held from Jan 18 - 24, 2025 at Grand Hyatt Kauai Resort & Spa, Kauai, Hawaii, United States of America.

Program Summary:
This program is designed by and for retina specialists, offering updates on the most recent advances and their integration into everyday practice as well as insight into varying challenges, including the implementation of new diagnostic and treatment modalities. In a relaxed setting, faculty and attendees can discuss specific cases, new therapy and imaging technologies and the latest surgical strategies. This program offers a non-concurrent schedule including: Breakfast programs, general sessions, exhibit breaks, lunch programs, workshops, banyan tree sessions and special events (all included in the single registration fee except the luau). Retina Program attendees are also able to attend sessions of interest under the Hawaiian Eye Comprehensive Ophthalmologist Program.

Learning Objectives: General Sessions (Monday to Friday)
Upon completion of this activity, attendees will have better knowledge of the following subject matters:

• Detail updates in imaging and new technologies, their use in evaluation and prognosis, and OCT findings and predictors in specific retinal diseases and conditions.
• Discuss abstract presentations on medical and surgical advances, as well as real-world findings that can improve retinal disease management.
• Assess the safety, efficacy, and use of new treatments in the management of age-related macular degeneration.
• Summarize the latest information about the management of macular degeneration, the use of drug delivery, gene therapy, as well as the treatment of geographic atrophy.
• Explore new insights on the management of diabetic eye disease including DRCR Retina Network trial data, the use of artificial intelligence, and retinal detachment repair.
• Examine management strategies for retinal vascular diseases including the detection of paracentral acute middle maculopathy, as well as the imaging and treatment of retinal vein occlusion.
• Review the utility of multi-modal imaging, use of anti-VEGF, and treatment of uveitis in pediatric patients.
• Describe current management strategies for uveitis, as well as for ocular tumors.
• Explore insights and practical considerations in the management of inherited retinal diseases, the use of gene and cell therapy, and optogenetic strategies for restoring vision.
• Assess techniques and technology that can improve retinal surgery outcomes including the management of diabetic retinopathy, floaters, retinal detachment, macular hole, as well as the use of 3D surgical systems.
• Examine best practices and clinical pearls for managing challenging retinal disorder case presentations.